ATE320487T1 - Ribozyme gegen eine hiv tat sequenz - Google Patents
Ribozyme gegen eine hiv tat sequenzInfo
- Publication number
- ATE320487T1 ATE320487T1 AT02025406T AT02025406T ATE320487T1 AT E320487 T1 ATE320487 T1 AT E320487T1 AT 02025406 T AT02025406 T AT 02025406T AT 02025406 T AT02025406 T AT 02025406T AT E320487 T1 ATE320487 T1 AT E320487T1
- Authority
- AT
- Austria
- Prior art keywords
- hiv
- compound
- target site
- ribozymes against
- act sequence
- Prior art date
Links
- 102000053642 Catalytic RNA Human genes 0.000 title abstract 2
- 108090000994 Catalytic RNA Proteins 0.000 title abstract 2
- 108091092562 ribozyme Proteins 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 4
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 238000013518 transcription Methods 0.000 abstract 2
- 230000035897 transcription Effects 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/122—Hairpin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/178,082 US5712384A (en) | 1994-01-05 | 1994-01-05 | Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
US08/310,259 US6114167A (en) | 1994-01-05 | 1994-09-21 | Ribozymes targeting the MoMLV PSI packaging sequence and the HIV tat sequence |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE320487T1 true ATE320487T1 (de) | 2006-04-15 |
Family
ID=26873946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02025406T ATE320487T1 (de) | 1994-01-05 | 1995-01-05 | Ribozyme gegen eine hiv tat sequenz |
Country Status (14)
Country | Link |
---|---|
EP (2) | EP1298208B1 (de) |
JP (1) | JP3691849B2 (de) |
CN (1) | CN1267552C (de) |
AT (1) | ATE320487T1 (de) |
AU (1) | AU698730B2 (de) |
CA (1) | CA2180358A1 (de) |
DE (1) | DE69534864T2 (de) |
DK (1) | DK1298208T3 (de) |
ES (1) | ES2260376T3 (de) |
IL (1) | IL112261A (de) |
NO (1) | NO319376B1 (de) |
NZ (1) | NZ278432A (de) |
PT (1) | PT1298208E (de) |
WO (1) | WO1995018854A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020058636A1 (en) * | 1994-09-21 | 2002-05-16 | Geoffrey P. Symonds | Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
NZ315890A (en) * | 1995-08-25 | 1998-10-28 | Univ California | Chimeric antiviral agents which incorporate rev binding nucleic acids |
ATE455858T1 (de) * | 1995-11-28 | 2010-02-15 | Univ Johns Hopkins Med | Konditionell replizierende virale vektoren und ihre verwendung |
US5888767A (en) | 1996-11-27 | 1999-03-30 | The Johns Hopkins University School Of Medicine | Method of using a conditionally replicating viral vector to express a gene |
US6776986B1 (en) | 1996-06-06 | 2004-08-17 | Novartis Ag | Inhibition of HIV-1 replication by antisense RNA expression |
US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
CZ295108B6 (cs) | 1998-03-20 | 2005-05-18 | Benitec Australia Ltd | Syntetický gen obsahující dispergovanou nebo cizorodou deoxyribonukleovou molekulu a genový konstrukt obsahující tento syntetický gen |
AU776150B2 (en) | 1999-01-28 | 2004-08-26 | Medical College Of Georgia Research Institute, Inc. | Composition and method for (in vivo) and (in vitro) attenuation of gene expression using double stranded RNA |
US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
EP1229134A3 (de) | 2001-01-31 | 2004-01-28 | Nucleonics, Inc | Verwendung von post-transkriptioneller Genabschaltung zur Identifizierung von Nukleinsäuresequenzen die die Funktion einer Zelle beeinflussen |
IL159637A0 (en) | 2001-07-10 | 2004-06-01 | Johnson & Johnson Res Pty Ltd | Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
ES2358187T3 (es) | 2001-07-10 | 2011-05-06 | JOHNSON & JOHNSON RESEARCH PTY LIMITED | Procedimientos para la modificación genética de las células progenitoras hematopoyéticas y utilizaciones de las células modificadas. |
CN102841007A (zh) * | 2012-09-05 | 2012-12-26 | 福建省农业科学院畜牧兽医研究所 | 一种便于鸭精子计数的精液稀释液及其使用方法 |
CN113549641B (zh) * | 2021-06-29 | 2023-12-22 | 复旦大学 | 一种核酶介导的多顺反子载体及其构建方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225337A (en) * | 1989-09-25 | 1993-07-06 | Innovir Laboratories, Inc. | Ribozyme compositions and methods for use |
AU655279B2 (en) * | 1991-04-05 | 1994-12-15 | Edison Animal Biotechnology Center | Retrovirus inhibition with antisense nucleic acids complementary to packaging sequences |
AU5961994A (en) * | 1993-01-22 | 1994-08-15 | University Research Corporation | Localization of therapeutic agents |
IL108719A0 (en) * | 1993-02-25 | 1994-08-26 | Ortho Pharma Corp | Expression constructs containing hiv inhibitory antisense and other nucleotide sequences, retroviralvectors and recombinant retroviruses containing them |
WO1995004818A1 (en) * | 1993-08-06 | 1995-02-16 | Ribozyme Pharmaceuticals, Inc. | Method and reagent for inhibiting human immunodeficiency virus replication |
-
1995
- 1995-01-05 AT AT02025406T patent/ATE320487T1/de not_active IP Right Cessation
- 1995-01-05 EP EP02025406A patent/EP1298208B1/de not_active Expired - Lifetime
- 1995-01-05 WO PCT/IB1995/000050 patent/WO1995018854A1/en not_active Application Discontinuation
- 1995-01-05 CA CA002180358A patent/CA2180358A1/en not_active Abandoned
- 1995-01-05 DK DK02025406T patent/DK1298208T3/da active
- 1995-01-05 DE DE69534864T patent/DE69534864T2/de not_active Expired - Lifetime
- 1995-01-05 IL IL11226195A patent/IL112261A/xx not_active IP Right Cessation
- 1995-01-05 CN CNB951919318A patent/CN1267552C/zh not_active Expired - Fee Related
- 1995-01-05 ES ES02025406T patent/ES2260376T3/es not_active Expired - Lifetime
- 1995-01-05 AU AU13912/95A patent/AU698730B2/en not_active Ceased
- 1995-01-05 JP JP51840395A patent/JP3691849B2/ja not_active Expired - Fee Related
- 1995-01-05 EP EP95905220A patent/EP0753062A4/de not_active Withdrawn
- 1995-01-05 NZ NZ278432A patent/NZ278432A/en not_active IP Right Cessation
- 1995-01-05 PT PT02025406T patent/PT1298208E/pt unknown
-
1996
- 1996-07-04 NO NO19962826A patent/NO319376B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69534864D1 (de) | 2006-05-11 |
IL112261A (en) | 2005-08-31 |
DE69534864T2 (de) | 2007-02-22 |
JP3691849B2 (ja) | 2005-09-07 |
AU698730B2 (en) | 1998-11-05 |
AU1391295A (en) | 1995-08-01 |
CN1145638A (zh) | 1997-03-19 |
EP1298208B1 (de) | 2006-03-15 |
WO1995018854A1 (en) | 1995-07-13 |
EP0753062A4 (de) | 1999-10-20 |
EP1298208A2 (de) | 2003-04-02 |
PT1298208E (pt) | 2006-10-31 |
CA2180358A1 (en) | 1995-07-13 |
NO962826D0 (no) | 1996-07-04 |
IL112261A0 (en) | 1995-03-30 |
JPH09508004A (ja) | 1997-08-19 |
NO962826L (no) | 1996-08-27 |
CN1267552C (zh) | 2006-08-02 |
EP0753062A1 (de) | 1997-01-15 |
NZ278432A (en) | 1998-06-26 |
EP1298208A3 (de) | 2004-01-07 |
DK1298208T3 (da) | 2006-07-24 |
NO319376B1 (no) | 2005-07-25 |
ES2260376T3 (es) | 2006-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE320487T1 (de) | Ribozyme gegen eine hiv tat sequenz | |
WO1999029871A3 (fr) | Sequences de circovirus associe a la maladie de l'amaigrissement du porcelet (map) | |
WO1996019568A3 (en) | Stabilized ribozyme analogs | |
CA2340416A1 (en) | Co-lyophilized complex of a nucleic acid vector and a formulating agent | |
CY1112430T1 (el) | Λεντινοϊικο τριπλο dνα και οχηματα και ανασυνδυασμενα κυτταρα που περιεχουν λεντινοϊικο τριπλο dνα | |
ATE154029T1 (de) | 7-deazapurin modifizierte oligonukleotide | |
KR950702626A (ko) | 치료제로서 자체-안정화된 올리고누클레오티드(self-stabilized loigonucleotides as therapeutic agents) | |
PT100472A (pt) | Sequencias genomicas do virus da hepatite c e composicoes farmaceuticas que as contem, para diagnostico e terapeutica da hepatite c | |
FR2741066B1 (fr) | Nouveaux agents de transfection et leurs applications pharmaceutiques | |
DZ1759A1 (fr) | Produits pharmaceutiques à base d'acide nucleique. | |
NO990025D0 (no) | Hamster-EF-1<alfa> transkripsjonsregulatorisk DNA | |
KR960703170A (ko) | 안티센스 올리고뉴클레오티드 및 인간면역결핍바이러스감염에서 그것의 치료적이용(antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection) | |
DE68927025D1 (de) | HIV-2-Virusvarianten | |
DK1175489T3 (da) | Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider | |
DK0404625T3 (da) | Oligonukleotidsekvenser til amplifikation af genomer af retrovirus af HIV-2 og SIV-typen samt deres anvendelser til in vitro-diagnose af infektioner forårsaget af disse virus | |
EP0329198A3 (de) | Ribose- und 2-Deoxyribose-Verbindungen | |
DK0775745T3 (da) | Cathepsin G-inhiberende aptamerer | |
FR2771753B1 (fr) | Gene de chitine-desacetylase, sequence d'adn hybridable, vecteur plasmidique qui le contient et organisme transforme par ce vecteur plasmidique | |
DE69501081D1 (de) | Oligonukleotide mit anti-cytomegalovirus wirkung | |
FR2701960B1 (fr) | Polyribozyme apte à conférer, aux plantes, une résistance aux virus et plantes résistantes produisant ce polyribozyme. | |
WO1998030717A3 (en) | Vegetal sequences including a polymorphic site and their uses | |
ATE156837T1 (de) | Gestagen wirksame 19,11-überbrückte 4-estrene | |
SE9804298D0 (sv) | New medical use | |
FR2734281B1 (fr) | Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1 | |
DE60027419D1 (de) | Regulatorische Sequenzen des humanen MCP-1 Gens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1298208 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |